Found: 12
Select item for more details and to access through your institution.
The role of social physique anxiety and other variables in predicting eating behaviors in college...
- Published in:
- International Journal of Sport Nutrition, 1997, v. 7, n. 4, p. 310, doi. 10.1123/ijsn.7.4.310
- By:
- Publication type:
- Article
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03182-y
- By:
- Publication type:
- Article
W Stands for Women: How the George W. Bush Presidency Shaped a New Politics of Gender – Edited by Michaele L. Ferguson and Lori Jo Marso.
- Published in:
- 2009
- By:
- Publication type:
- Book Review
Efficacy and Safety of PF‐06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate‐to‐Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 10, p. 1621, doi. 10.1002/art.41316
- By:
- Publication type:
- Article
The Influence of Physical Activity, Socioeconomic Status, and Ethnicity on the Weight Status of Adolescents.
- Published in:
- Obesity (19307381), 2000, v. 8, n. 2, p. 130, doi. 10.1038/oby.2000.14
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 307, doi. 10.1002/cpdd.887
- By:
- Publication type:
- Article
Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, shows efficacy in patients with active nonsegmental vitiligo and either a lighter or darker Fitzpatrick skin type: results from a phase 2b, randomized, doseranging study with an extension period.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. i3, doi. 10.1093/bjd/ljac106.004
- By:
- Publication type:
- Article
Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, stabilizes active lesions and promotes re-pigmentation of stable lesions in patients with active nonsegmental vitiligo: results from a phase 2b, randomized, placebocontrolled, dose-ranging study.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. i1, doi. 10.1093/bjd/ljac106.002
- By:
- Publication type:
- Article
Amnon Cavari. The Party Politics of Presidential Rhetoric. New York: Cambridge University Press. 2017. 246 pp. $99.99 (cloth). $29.99 (paper).
- Published in:
- 2018
- By:
- Publication type:
- Book Review
An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo.
- Published in:
- British Journal of Dermatology, 2024, v. 191, n. 3, p. 453, doi. 10.1093/bjd/ljad436
- By:
- Publication type:
- Article
Comparing the Self-Reported Health, Happiness, and Marital Happiness of a Multinational Sample of Consensually Non-Monogamous Adults with Those of the U.S. General Population: Additional Comparisons by Gender, Number of Sexual Partners, Frequency of Sex, and Marital Status
- Published in:
- Archives of Sexual Behavior, 2021, v. 50, n. 4, p. 1287, doi. 10.1007/s10508-021-01973-2
- By:
- Publication type:
- Article
Multiplex assessment of serum cytokine and chemokine levels in idiopathic morphea and vitamin K-induced morphea.
- Published in:
- Clinical Rheumatology, 2017, v. 36, n. 5, p. 1173, doi. 10.1007/s10067-017-3580-2
- By:
- Publication type:
- Article